Author: ksandness
-
Medicines360 Applauds U.S. Congress for Enshrining Nonprofit Pharma in Federal Law for the First Time
-
FDA Approves Medicines360’s LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years
-
Medicines360 Calls on U.S. Congress to Pass Affordability is Access Act Without Delay
-
Defying Definitions and Breaking Down Barriers: Lessons from Medicines360’s Nonprofit Journey
-
In the Wake of Supreme Court Decision, Medicines360 Stands With Women
-
Medicines360 Applauds HELP Committee for Including Critical Amendments on Nonprofit Pharma in Legislation Headed to Senate Floor